
Philips Sees Positive Turn in Order Intake as Recall Challenges Diminish
Philips, the renowned Dutch healthcare technology company, has recently reported a notable rebound in its order intake, marking a significant milestone as the company continues to recover from previous product recalls that had severely impacted its operations. This positive news comes as the challenges stemming from these recalls begin to fade, allowing Philips to regain its footing in the competitive healthcare market.
Continue reading
Philips Divests Emergency Care Business in Strategic Move to Bridgefield Capital
In a notable shift within the healthcare technology landscape, Philips has announced the sale of its emergency care business to Bridgefield Capital. This strategic move is part of Philips' broader initiative to refocus its operational priorities and streamline its offerings amid a challenging market landscape.
Continue reading
Philips CEO Urges EU to Embrace AI Innovation Amid Regulatory Concerns
In a recent address, Philips CEO Roy Jakobs emphasized the critical need for the European Union (EU) to foster an environment conducive to artificial intelligence (AI) development rather than stifle it with burdensome regulations. Jakobs voiced his concerns during a media conference, where he argued that excessive regulatory measures could hinder technological advancement and innovation, particularly in healthcare and consumer electronics.
Continue reading
Philips CEO Roy Jakobs on Resurrecting Trust, Monetizing AI, and the Path to Immortality
In this candid discussion, Philips CEO Roy Jakobs talks about the company's ambitious journey to regain public trust, pioneer AI for profit, and-baically-so find out whether human life can be extended indefinitely. Set against a backdrop of challenges and opportunities, Jakobs lays out a vision for Philips that seeks to blend technological innovation with ethical rigor in a rejuvenation of its brand, one that engages with the profoundly transformative potential of breakthroughs in AI and healthcare.
Continue reading